A Novel Human Growth Hormone XTEN Construct (VRS-317) for Once-a-Month Subcutaneous Administration in a Phase 1a Study of Growth Hormone–Deficient AdultsJeffrey L. Cleland, Mark Kipnes, Benjamin Spink et al.|Unknown|2011Cited by 0